`
`
`
`
`
`
`
`
`
`
`Filed: June 6, 2019
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC.
`Petitioner,
`
`v.
`
`BIOGEN MA, INC.
`Patent Owner.
`
`
`
`
`Case No. IPR2018-01403
`Patent No. 8,399,514
`
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICES PURSUANT TO
`37 C.F.R. §§ 42.8(a)(3), 42.8(b)(3) AND 42.8(b)(4)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. §§ 42.8(a)(3), 42.8(b)(3) and 42.8(b)(4) Petitioner
`
`Mylan Pharmaceuticals Inc. (“Mylan”), hereby submits an updated identification
`
`of counsel and service information.
`
`C.
`
`Identification of Counsel (37 C.F.R. § 42.8(b)(3))
`
`Mylan updates its identification of counsel to include David L. Anstaett as
`
`additional back up counsel. All other counsel remains the same.
`
`Back Up Counsel
`Emily J. Greb
`(Reg. No. 68,244)
`Perkins Coie LLP
`33 East Main Street, Suite 201
`Madison, WI 53703
`EGreb@perkinscoie.com
`Tel: (608) 663-7494
`Fax: (608) 283-4494
`
`
`
`Lead Counsel
`Brandon M. White
`(Reg. No. 52,354)
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, DC 20005
`BMWhite@perkinscoie.com
`Tel: (202) 654-6206
`Fax: (202) 654-9681
`Additional Back Up Counsel
`David L. Anstaett
`(admitted pro hac vice)
`Perkins Coie LLP
`33 East Main Street, Suite 201
`Madison, WI 53703
`DAnstaett@perkinscoie.com
`Tel: (608) 663-5408
`Fax: (608) 663-7499
`D.
`Service Information (37 C.F.R. § 42.8(b)(4))
`
`Please direct all correspondence to lead counsel and back-up counsel at the
`
`contact information above. Mylan consents to service by electronic mail at
`
`bmwhite@perkinscoie.com, egreb@perkinscoie.com, danstaett@perkinscoie.com,
`
`
`
`
`
`
`
`and tecfidera@perkinscoie.com.
`
`Dated: June 6, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Emily J. Greb
`Emily J. Greb
`Reg. No. 68,244
`Perkins Coie LLP
` 33 East Main Street, Suite 201
`Madison, WI 53703
`Telephone: (608) 663-7494
`E-mail: EGreb@perkinscoie.com
`
`2
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served a true and
`
`correct copy of the foregoing: PETITIONER’S UPDATED MANDATORY
`
`NOTICES PURSUANT TO 37 C.F.R. §§ 42.8(a)(3), 42.8(b)(3) AND 42.8(b)(4)
`
`by email to the electronic service addresses for Patent Owners:
`
`Barbara C. McCurdy
`Mark J. Feldstein
`Erin M. Sommers
`Pier D. DeRoo
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`barbara.mccurdy@finnegan.com
`mark.feldstein@finnegan.com
`erin.sommers@finnegan.com
`pier.deroo@finnegan.com
`
`
`
`
`
`
`
`
`
`
`
`Counsel for Patent Owner
`/s/Emily J. Greb
`Dated: June 6, 2019
`Emily J. Greb
`Reg. No. 68,244
`
`
`
`
`
`Counsel for Petitioner Mylan Pharmaceuticals Inc.
`
`
`
`